Recent advances in SMANCS/Lipiodol therapy—enhanced targeting and delivery efficacy using vascular modulators

Drug Delivery System

Volumn 18, Issue 5, 2003, Pages 438-447

  Nagamitsu, Akinori ^a,b   Inuzuka, Takao ^b   Kawasuji, Michio ^b   Maeda, Hiroshi ^b  

^a Hakuaikai Hospital   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

enhanced targeting delivery; hypertension; SMANCS therapy; vasodilatation

Indexed keywords

EID: 84967637231     PISSN: 09135006     EISSN: 18812732     Source Type: Journal    
DOI: 10.2745/dds.18.438     Document Type: Article

References (16)

1. Iwai K, Maeda H, Konno T : Use of oily contrast medium for selective drug targeting to tumor : Enhanced therapeutic effect and X-ray image. Cancer Res 44 : 2115-2121, 1984.
2. Maki S, Konno T, Maeda H : Image enhancement in computerized tomography for sensitive diagnosis of liver cancer and semiquantitation of tumor selective drug targeting with oily contrast medium. Cancer 56 : 751-757, 1985.
3. Konno T, Maeda H, Iwai K, Maki S, Tashiro S et al. : Selective targeting of anti-cancer drug and simultaneous image enhancement in solid tumors by arterially administered lipid contrast medium. Cancer 54 : 2367-2374, 1984.
4. Matsumura Y, Maeda H : A new concept for macromolecular therapeutics in cancer chemotherapy : Mechanisum of tumoritropic accumulation of proteins and the antitumor agent smanos. Cancer Res 46 : 6387-6392, 1986.
5. Maeda H, Matsumura Y : Tumoritropic and lymphotropic principles of macromolecular drugs. Crit Rev Therap Drug Carrier Systems 6 : 193-210, 1989.
6. Maeda H : SMANCS and polymer-conjugated macromolecular drugs : Advantages in cancer chemotherapy. Adv Drug Delivery Rev 6 : 181-202, 1991.
7. Maeda H, Wu J, Sawa T, Matsumura Y, Hori K : [Review] Tumor vascular permeability and the EPR effect in macromolecular therapeutics. J Controlled Release 65 : 271-284, 2000.
8. Maeda H, Sawa T, Konno T : Mechanism of tumor-targeted deliverly of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. J Controlled Release 74 : 47-61, 2001.
9. Noguchi Y, Wu J, Duncan R, Strohalm J, Ulbrich K, Akaike T, Maeda H : Early phase tumor accumulation of macromolecules : A great difference in clearance rate between tumor and normal tissues. Jpn J Cancer Res 89 : 307-314, 1998.
10. Suzuki M, Hori K, Abe I, Saito S, Sato H : A new approach to cancer chemotherapy : selective enhancement of tumor blood flow with angiotensin II. J Natl Cancer Inst 67 : 663-669, 1981.
11. Li CJ, Miyamoto Y, Kojima Y, Maeda H : Augmentation of tumour delivery of macromolecular drugs with reduced bone marrow delivery by elevating blood pressure. Br J Cancer 67 : 975-980, 1993.
12. Hori K, Saito S, Takahashi H, Sato H, Maeda H et al. : Tumor-selective blood flow decrease induced by an angiotensin converting enzyme inhibitor, temocapril hydrochloride. Jpn J Cancer Res 91 : 261-269, 2000.
13. Tanaka S, Akaike T, Wu J, Fang J, Sawa T et al. : Modulation of tumor-selective vascular blond flow and extravasation by the stable prostaglandin I2 analogue heraprost sodium. J Drug Targeting 11 : 45-52, 2003.
14. Maeda H, Noguchi Y, Sato K, Akaike T : Enhanced vascular permeability in solid tumor is mediated by nitric oxide and inhibited by both new nitric oxide scavenger and nitric oxide synthase inhibitor. Jpn J Cancer Res 85 : 331-334, 1994.
15. Wu J, Akaike T, Maeda H : Modulation of enhanced vascular permeability in tumors by a bradykinin antagonist, a cyclooxygenase inhibitor, and a nitric oxide scavenger. Cancer Res 58 : 159-165, 1998.
16. Matsumura Y, Kimura M, Yamamoto T, Maeda H : Involvement of the kinin generating cascade in tumor tissue. Jpn J Cancer Res 79 : 1372-1334, 1988.